-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the context of changes in the pharmaceutical industry environment, changes in pharmaceutical company executives are frequently staged
.
In the past week (November 1st to 7th), many senior executives of pharmaceutical companies have joined the wave of resignations, involving Sinopharm Accord, Huanhai Biological, Yasheng Pharmaceutical, Ruizhi Pharmaceutical, and Jinshi Yayao
.
Sinopharm Unanimous: Director Zhou Song resigns On November 2, Sinopharm Unanimous issued an announcement on the resignation of directors
.
According to the announcement, Zhou Song applied for resignation as a director of the 9th Board of Directors of Sinopharm Accord, a member of the Risk Internal Control and Audit Committee of the Board of Directors, and a member of the Legal Compliance Committee of the Board of Directors of Sinopharm Accord due to work arrangements.
He will no longer hold any other positions in Sinopharm Accord
.
Huanhai Bio: The person in charge of finance resigns November 2 The resignation takes effect
.
Zhao Shunyi no longer holds other positions in the company after his resignation
.
It is reported that Zhao Shunyi resigned as the head of finance due to personal reasons
.
Yasheng Pharmaceuticals: Chief Financial Officer Resigns On November 2, Yasheng Pharmaceuticals announced that Mr.
Zhang Su hopes to devote more time and energy to other businesses and has decided to resign as Chief Financial Officer from November 1, 2021
.
The company also stated that it will look for candidates as soon as possible to fill the vacancies
.
Corning Jerry: New Chief Commercial Officer On November 2, Corning Jerry announced that Mr.
Han Jing has been appointed as the Chief Commercial Officer, mainly responsible for the company's commercial promotion
.
It is reported that Mr.
Han Jing has more than 20 years of extensive experience in pharmaceutical sales and marketing in Shanghai Roche, AstraZeneca, Bayer and other multinational pharmaceutical companies
.
Wisdom Medicine: Chairman resigns Wisdom Medicine announced on November 1 that WOO SWEE LIAN has applied to resign from the company's chairman, director, and chairman of the board's strategy committee due to personal reasons, and will continue to serve as the company's strategic consultant after resignation
.
After review by the board of directors, it was agreed to nominate Fan Shixin as a candidate for non-independent director of the fifth board of directors of the company
.
WuXi Biologics: Change of Chief Financial Officer On November 1, WuXi Biologics announced that Ms.
Lu Shaohua has retired and resigned as Chief Financial Officer to devote more time to her personal affairs
.
At the same time, the board of directors announced that Mr.
Tu Ming has been appointed as the chief financial officer to succeed Ms.
Lu, and will be responsible for overseeing the Group's financial strategy, performance, reporting and business planning, as well as operational support such as funding, taxation, accounting management and auditing
.
Kingstone Asia Pharmaceuticals: Deputy General Manager (Vice President) Resigns News on November 1st, the board of directors of Kingstone Asia Pharmaceuticals recently received a written resignation report submitted by the company's director and deputy general manager (Vice President) Zheng Zhiyong.
Zheng Zhiyong applied to resign from the company for personal reasons.
Deputy General Manager (Vice President), after resignation, he still serves as a director of the company's fourth board of directors and a member of the nomination committee of the board of directors
.
As of the date of this announcement, Zheng Zhiyong directly holds 4.
2669 million shares of the company, accounting for 1.
06% of the company's total share capital
.
The shares held by Zheng Zhiyong will still be managed in strict accordance with relevant laws, regulations and commitments
.
Tianjing Biology: Changes in several executives On November 1, Tianjing Biology announced two important executive appointments
.
With immediate effect, Mr.
Long Jiang (John Long) will serve as the chief financial officer of Tianjing Biotech and will join the company's board of directors, reporting directly to the company's founder and chairman Dr.
Zang Jingwu
.
At the same time, with immediate effect, Mr.
Zhu Jielun will be transferred to the company's chief strategy officer, focusing on planning and advancing corporate development strategies, major company strategic projects (including global cooperation, strategic investment and potential mergers and acquisitions), and early-stage venture capital
.
He will also assist Mr.
Long Jiang to successfully complete the work handover
.
.
In the past week (November 1st to 7th), many senior executives of pharmaceutical companies have joined the wave of resignations, involving Sinopharm Accord, Huanhai Biological, Yasheng Pharmaceutical, Ruizhi Pharmaceutical, and Jinshi Yayao
.
Sinopharm Unanimous: Director Zhou Song resigns On November 2, Sinopharm Unanimous issued an announcement on the resignation of directors
.
According to the announcement, Zhou Song applied for resignation as a director of the 9th Board of Directors of Sinopharm Accord, a member of the Risk Internal Control and Audit Committee of the Board of Directors, and a member of the Legal Compliance Committee of the Board of Directors of Sinopharm Accord due to work arrangements.
He will no longer hold any other positions in Sinopharm Accord
.
Huanhai Bio: The person in charge of finance resigns November 2 The resignation takes effect
.
Zhao Shunyi no longer holds other positions in the company after his resignation
.
It is reported that Zhao Shunyi resigned as the head of finance due to personal reasons
.
Yasheng Pharmaceuticals: Chief Financial Officer Resigns On November 2, Yasheng Pharmaceuticals announced that Mr.
Zhang Su hopes to devote more time and energy to other businesses and has decided to resign as Chief Financial Officer from November 1, 2021
.
The company also stated that it will look for candidates as soon as possible to fill the vacancies
.
Corning Jerry: New Chief Commercial Officer On November 2, Corning Jerry announced that Mr.
Han Jing has been appointed as the Chief Commercial Officer, mainly responsible for the company's commercial promotion
.
It is reported that Mr.
Han Jing has more than 20 years of extensive experience in pharmaceutical sales and marketing in Shanghai Roche, AstraZeneca, Bayer and other multinational pharmaceutical companies
.
Wisdom Medicine: Chairman resigns Wisdom Medicine announced on November 1 that WOO SWEE LIAN has applied to resign from the company's chairman, director, and chairman of the board's strategy committee due to personal reasons, and will continue to serve as the company's strategic consultant after resignation
.
After review by the board of directors, it was agreed to nominate Fan Shixin as a candidate for non-independent director of the fifth board of directors of the company
.
WuXi Biologics: Change of Chief Financial Officer On November 1, WuXi Biologics announced that Ms.
Lu Shaohua has retired and resigned as Chief Financial Officer to devote more time to her personal affairs
.
At the same time, the board of directors announced that Mr.
Tu Ming has been appointed as the chief financial officer to succeed Ms.
Lu, and will be responsible for overseeing the Group's financial strategy, performance, reporting and business planning, as well as operational support such as funding, taxation, accounting management and auditing
.
Kingstone Asia Pharmaceuticals: Deputy General Manager (Vice President) Resigns News on November 1st, the board of directors of Kingstone Asia Pharmaceuticals recently received a written resignation report submitted by the company's director and deputy general manager (Vice President) Zheng Zhiyong.
Zheng Zhiyong applied to resign from the company for personal reasons.
Deputy General Manager (Vice President), after resignation, he still serves as a director of the company's fourth board of directors and a member of the nomination committee of the board of directors
.
As of the date of this announcement, Zheng Zhiyong directly holds 4.
2669 million shares of the company, accounting for 1.
06% of the company's total share capital
.
The shares held by Zheng Zhiyong will still be managed in strict accordance with relevant laws, regulations and commitments
.
Tianjing Biology: Changes in several executives On November 1, Tianjing Biology announced two important executive appointments
.
With immediate effect, Mr.
Long Jiang (John Long) will serve as the chief financial officer of Tianjing Biotech and will join the company's board of directors, reporting directly to the company's founder and chairman Dr.
Zang Jingwu
.
At the same time, with immediate effect, Mr.
Zhu Jielun will be transferred to the company's chief strategy officer, focusing on planning and advancing corporate development strategies, major company strategic projects (including global cooperation, strategic investment and potential mergers and acquisitions), and early-stage venture capital
.
He will also assist Mr.
Long Jiang to successfully complete the work handover
.
